Stocks St. Jude Medical Inc

  • Following are the day’s biggest winners and losers. Find out why shares of SanDisk and the Brazil ETF popped while Northern Trust and Altria dropped.

  • Stocks finished lower after well-known banking analyst Dick Bove downgraded his rating on Wells Fargo.

  • Stocks advanced Wednesday as investors were encouraged by a few earnings reports, including Morgan Stanley, Yahoo and SanDisk. The VIX, widely considered the best gauge of fear in the market, dropped to just above 20.

  • Stocks opened lower Wednesday as a raft of companies beating earning estimates but failed to impress investors.

  • Earnings season continues in earnest Wednesday, as we roll on with a week that will ultimately see 25 percent of the S&P 500 report their quarterly numbers. 

  • Following are the day’s biggest winners and losers. Find out why shares of Mosaic and NutriSystem popped while Vimpel-Comm and St. Jude Medical dropped.

  • MM_promo_Cramerica_Challenge_530x50.jpg

    Plus, the Mad Money host makes a call on medical stocks and tells viewers what is driving this market.

  • Global stock markets are higher overnight due to...Australia? Yep. The central bank there became the first G20 country to raise interest rates, by 25 basis points to 3.25 points. The Australian dollar jumped to a 14-month high, and stocks rose as well.

  • Cramer makes the call on viewers' favorite stocks.

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • Hint: The real story in the sector has nothing to do with President Obama.

  • Boston Scientific has rallied back to its highest levels since last year's financial crisis and is scheduled to discuss a key defibrillator trial this morning, prompting one large investor to position for a potential decline.

  • The Dow and S&P snapped their winning streaks Wednesday as disappointing earnings from two of Wall Street's biggest names overshadowed another round of earnings beats.

  • Stocks wobbled Wednesday as a slew of earnings beats, including one from Pfizer, were encouraging but disappointing reports from two of Wall Street's biggest names dragged on the market.

  • Stocks wobbled Wednesday as a slew of earnings beats, including one from Pfizer, were encouraging but disappointing reports from two of Wall Street's biggest names dragged on the market.

  • Futures indicated a lower open for Wall Street Wednesday as cautious words from Federal Reserve Chairman Ben Bernanke and Yahoo's missing revenue expectations lent to investors taking profits.

  • This sector offers long-term growth, even in a slowdown. Even oil can’t promise that.

  • graphic_word_ofthe_street.jpg

    The market traded sideways on Tuesday with Dow finishing slightly lower and the S&P 500 closing a little higher.

  • Russia's RTS Index was the first global index to hit the correction stage (down 23 percent since hitting its recent high on June 2nd), but now the MSCI Emerging Markets Index (EEM in its ETF form) is also down double-digits since hitting its recent high on June 1st.

  • boston_scientific.jpg

    This takes the prize for the most dangerously optimistic acronym for a clinical trial. But MADIT (pronounced "made it") made it. Some folks with a lot of chutzpah at Guidant, now owned by Boston Scientific, apparently came up with the name for their big studies on implantable cardio defibrillators.